Code
|
28653
|
MA number
|
59/0069/99-S
|
Product Form:
|
plv isl 1x0,5 ml+1x0,5 ml solv. (liek.inj.skl.+striek.inj.skl.napl.)
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
Type of procedure:
|
Mutual recognition procedure
|
MAH, country:
|
GlaxoSmithKline Biologicals S.A., Belgium
|
Therapeutic Class:
|
59 - IMMUNOPRAEPARATA
|
ATC:
|
J |
ANTIINFECTIVES FOR SYSTEMIC USE |
J07 |
VACCINES |
J07B |
VIRAL VACCINES |
J07BD |
Measles vaccines (old: Morbilli vaccines) |
J07BD52 |
Measles, co. w. mumps a. rubella, l. att. (old: Morbilli, co. w. parotit. a. rub., li. att.) |
|
Shelf life:
|
24 |
Container:
|
glass vial
|
Route of admin.:
|
Subcutaneous use
|